Micro-instrumentation reduces trauma in IOL exchangeIncreased procedure volume and patient expectations have made IOL exchange procedures more common. Smaller incisions and the need to reduce trauma require new micro-instrumentation for best outcomes.
In this issue
Ocular surface tumors require careful exam, consideration of best options June 15, 2017By Vanessa CaceresAlthough surgery is still the gold standard for ocular surface tumors, consider the pros and cons of topical chemotherapy as appropriate. Natamycin still the best bet for fungal keratitis June 21, 2017By Lynda ChartersA recent study sponsored by the National Eye Institute (NEI) of the optimal treatments for fungal keratitis showed that topical natamycin is still the mainstay of treatment. Adding oral voriconazole to the treatment regimen also may be beneficial to treat patients with Fusarium species. New pathways to cancer therapyA novel oral formulation of itraconazole (SUBA-Itraconazole, HedgePath Pharmaceuticals) is providing dramatic benefit for patients with basal cell carcinoma nevus syndrome (BCCNS, also known as Gorlin syndrome) and with a favorable safety profile, according to a recent interim analysis of data collected in a phase IIb study. A wake-up call for physiciansEveryone knows the name of Warren Buffett, the famous octogenarian-billionaire businessman and investor. His folksy persona and investment insights/elevated returns have earned him the appellation of “The Oracle of Omaha.” His estimated net worth of more than $74 billion makes him one of the wealthiest people on the planet. Quantifying ectasia risk after LASIK June 15, 2017By Fred GebhartA preliminary analysis of a dataset containing more than 300,000 eyes treated with LASIK between 6 to 10 years ago is beginning to quantify some of the risks for ectasia. POAG: Enigmatic group of heterogenous diseases? June 15, 2017By Lynda ChartersVarious subtypes of primary open-angle glaucoma might exist. Continued research is needed to identify the characteristics of each subtype for better management. Managing conjunctival pigmented lesionsKnowing how to recognize and manage the various forms of conjunctival pigmented lesions can literally mean the difference between life and death in some cases. Aspiring for zero tolerance of residual astigmatismWhen considering premium surgeries and high expectations from patients along with an unrelenting quest for vision exceeding 20/20, the tolerance of residual astigmatism must be zero. Like bespoke tailors, ophthalmologists need to be bespoke surgeons who tailor vision in each eye to the highest level possible. We cannot claim to design the best suit using the best technology and tailoring materials, and yet, in our minds, find it “acceptable” to have the suit length within a half-inch to three-quarters of an inch too short or wide.